Skip to main content
logo
Coegin Pharma AB (NGM:COEGIN)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.080
+0.020 (0.65%)
At close: Jul 30, 2026

Coegin Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.370.08----
Revenue Growth
------
Gross Profit
-0.63-0.77-0.02-0.02--
Operating Income
-19.58-20.45-23.33-27.82-34.69-27.18
Net Income
-19.7-20.5-23.78-27.98-35.24-27.15
Earnings Per Share
-0.79-0.82-1.26-3.04-5.14-4.59
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
9.277.9219.685.553.8225.66
Net Cash Growth
-40.47%-59.74%254.70%45.39%-85.13%54.12%
Net Cash Per Share
0.370.321.040.600.564.32
Cash & Investments
9.277.9219.685.553.8225.66

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-18.07-16.55-23.64-22.03-38.23-21.49
Capital Expenditures
-0.12-0.12----
Free Cash Flow
-18.19-16.67-23.64-22.03-38.23-21.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-5277.09%-25889.87%----
Pretax Margin
-5304.31%-25925.32%----
Profit Margin
-5308.63%-25945.57%----
FCF Margin
-4903.50%-21101.27%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
237.361398.18----